These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21221076)

  • 1. Similarity trials.
    Nat Biotechnol; 2011 Jan; 29(1):1. PubMed ID: 21221076
    [No Abstract]   [Full Text] [Related]  

  • 2. EU directive on clinical trials penalizes small sponsors.
    Meldolesi A
    Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
    [No Abstract]   [Full Text] [Related]  

  • 3. Performing phase I clinical trials of anticancer agents: perspectives from within the European union and Japan.
    Forster MD; Saijo N; Seymour L; Calvert H
    Clin Cancer Res; 2010 Mar; 16(6):1737-44. PubMed ID: 20215555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Biosimilar' drugs poised to penetrate market.
    Ledford H
    Nature; 2010 Nov; 468(7320):18-9. PubMed ID: 21048737
    [No Abstract]   [Full Text] [Related]  

  • 7. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 8. Tysabri back on market.
    Sheridan C
    Nat Biotechnol; 2006 Aug; 24(8):874. PubMed ID: 16900111
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug research and its international harmonization].
    Idänpään-Heikkilä JE
    Duodecim; 1998; 114(10):951, 953-4. PubMed ID: 11524783
    [No Abstract]   [Full Text] [Related]  

  • 10. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 11. The gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making.
    Brass EP
    Clin Pharmacol Ther; 2010 Mar; 87(3):351-5. PubMed ID: 20010554
    [No Abstract]   [Full Text] [Related]  

  • 12. Researchers see a need for speed in EU trial approvals.
    Cressey D
    Nat Med; 2008 Aug; 14(8):794. PubMed ID: 18685580
    [No Abstract]   [Full Text] [Related]  

  • 13. Performing trials in children with rheumatic diseases: comment on the editorial by Lehman.
    Ruperto N; Martini A; Lovell DJ; Giannini EH; ;
    Arthritis Rheum; 2008 Apr; 58(4):1201-2; author reply 1203. PubMed ID: 18383366
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug regulation in the European Union.
    Griffin JP
    Adverse Drug React Toxicol Rev; 2000 Aug; 19(3):179-206. PubMed ID: 11059359
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibodies market.
    Reichert J; Pavolu A
    Nat Rev Drug Discov; 2004 May; 3(5):383-4. PubMed ID: 15152631
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug marketing exclusivity under United States and European Union law.
    Junod V
    Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347
    [No Abstract]   [Full Text] [Related]  

  • 17. EU law mandates drug testing in children.
    Sinha G
    J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical research on humans: regulation in Switzerland, the European Union, and the United States.
    Schott M
    Food Drug Law J; 2005; 60(1):45-77. PubMed ID: 15940854
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods.
    Browne TR
    Epilepsy Res Suppl; 1993; 10():31-44. PubMed ID: 8251105
    [No Abstract]   [Full Text] [Related]  

  • 20. Consequences.
    Nat Biotechnol; 2006 Apr; 24(4):368. PubMed ID: 16601704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.